2025-12-21 - Analysis Report
Okay, here's a report summarizing the provided information on Rocket Lab USA Inc. (RKLB), formatted for readability and clarity.

**Rocket Lab USA Inc. (RKLB) Report**

Rocket Lab USA Inc. is an end-to-end space company delivering launch services, space systems, and on-orbit management.

**1) Return Rate Analysis**

*   **RKLB Cumulative Return:** 428.5%
*   **VOO (S&P 500) Cumulative Return:** 50.3%
*   **Divergence:**
    *   Current: 266.6
    *   Relative Divergence: 72.5 (meaning it is at 72.5% position of its divergence between the maximum and minimum divergence in history)

    *Analysis:* RKLB has significantly outperformed the S&P 500. The relative divergence suggests that while the outperformance is substantial, there is still room for further gains based on historical data.

*   **Alpha, Beta, CAGR, MDD Analysis**

    | Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
    |------------|--------|-------|--------|------|--------|
    | 2020-2022  | -38.0% | 82.7% | -18.0% | 0.1  | 2.0    |
    | 2021-2023  | 3.0%   | 82.7% | 2.0%   | 0.0  | 3.0    |
    | 2022-2024  | 210.0% | 82.7% | 189.0% | 0.0  | 13.6   |
    | 2023-2025  | 448.0% | 79.6% | 383.0% | -0.0 | 37.7   |

    *Analysis:* Recent years show significant improvements in CAGR and Alpha. The Beta near 0 suggests that RKLB's price is quite independent of the broad market S&P 500 index. The high MDD values reflects the high risk associated with a growth stock.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 70.52
*   **Previous Close:** 59.92
*   **Change:** 17.69%
*   **5-day SMA:** 59.06
*   **20-day SMA:** 50.95
*   **60-day SMA:** 55.03

    *Analysis:* The current price is significantly above the 5-day, 20-day, and 60-day moving averages. This indicates a strong upward trend and potentially overbought conditions in the short term. The large price change from the previous close confirms significant volatility.

**3) Market Risk Indicator and Other Indicators**

*   **MRI:** 0.7 (Medium Investment Recommended)
*   **RSI:** 79.83 (Overbought)
*   **PPO:** 3.76
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 3.8 (+) (short-term increase)
*   **Expected Return:** 9.1% (over 2 years, relative to S&P 500)

    *Analysis:* The RSI indicates that the stock may be overbought and due for a correction. The PPO is positive, suggesting an upward trend. The MRI suggests a medium investment risk, while the hybrid signal is relatively safe.  The positive relative divergence change confirms short-term upward momentum. The high price fluctuation reflects the high volatility.

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   Rocket Lab (RKLB) Stock Soaring (Yahoo Finance)
    *   Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win (ts2.tech)
    *   Rocket Lab Scores Breakout On Record Contract Win, Stock Up 29% In Two Days (Investor's Business Daily)
    *   Rocket Lab’s Recent Triumphs Propel Stock Amidst Strategic Milestones (StocksToTrade)
    *   Rocket Lab (RKLB) Stock in Focus on Dec. 20, 2025: $816M SDA Satellite Win, Faster Launch Cadence, and Neutron’s 2026 Countdown (ts2.tech)

    *Analysis:* Recent news is overwhelmingly positive, driven by a major contract win, which has significantly boosted the stock price. This positive sentiment is a strong driver of the recent price surge.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.79)
*   **Target Price:**
    *   Average: 66.50
    *   High: 85.00
    *   Low: 47.00

    *Analysis:* The analyst consensus is 'Buy,' although the current price is above the average target price, implying that the price is exceeding analyst estimates.

**5) Recent Earnings Analysis**

| Date       | EPS    | Revenue      |
|------------|--------|--------------|
| 2025-11-10 | -0.03  | 0.16 B$      |
| 2025-08-07 | -0.13  | 0.14 B$      |
| 2025-05-08 | -0.12  | 0.12 B$      |
| 2024-11-12 | -0.1   | 0.10 B$      |
| 2025-11-10 | -0.1   | 0.10 B$      |

    *Analysis:* While the company is not yet profitable (negative EPS), revenue is trending upwards. The most recent EPS shows a marked improvement (-0.03) compared to prior quarters.

**6) Financial Information**

*Revenue and Profitability:*

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $0.16B    | 36.96%        |
| 2025-06-30   | $0.14B    | 32.10%        |
| 2025-03-31   | $0.12B    | 28.76%        |
| 2024-12-31   | $0.13B    | 27.81%        |
| 2024-09-30   | $0.10B    | 26.71%        |

*Capital and Profitability:*

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-09-30   | $1.28B    | -1.43%    |
| 2025-06-30   | $0.69B    | -9.65%    |
| 2025-03-31   | $0.43B    | -14.05%   |
| 2024-12-31   | $0.38B    | -13.69%   |
| 2024-09-30   | $0.42B    | -12.37%   |

    *Analysis:* Revenue and profit margins are increasing, indicating improved operational efficiency. Equity is also rising significantly. While ROE remains negative, it's trending upwards, suggesting a move towards profitability.

**7) Comprehensive Analysis**

Rocket Lab (RKLB) has experienced a significant surge in stock price driven by a major contract win and positive news sentiment. The company is showing strong revenue growth and improving profit margins. Although not yet profitable, the trend in EPS and ROE indicates progress towards profitability.  The stock appears overbought in the short term based on technical indicators. The analyst consensus is positive, but the current price exceeds the average target. The relatively high MRI indicates a risk associated with the growth stock. The recent positive performance needs to be balanced against the potential for a pullback.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.